Orgenesis Enters Material Definitive Agreement on Jan 29
Ticker: ORGS · Form: 8-K · Filed: Jan 31, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Jan 31, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $40 m, $40 million, $300,000, $2,600,000 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
**Orgenesis just signed a big deal; details pending but it's a material event.**
AI Summary
Orgenesis Inc. (ORGS) filed an 8-K on January 31, 2024, reporting a material definitive agreement entered into on January 29, 2024. This filing indicates a significant corporate action, likely a new contract or partnership, which could impact the company's future operations and financial performance. For investors, this matters because such agreements can be catalysts for growth or present new challenges, directly affecting the stock's valuation.
Why It Matters
This filing signals a new, important business arrangement for Orgenesis, which could significantly alter its operational trajectory and financial outlook. Investors should monitor for details of this agreement to assess its potential impact on revenue and profitability.
Risk Assessment
Risk Level: medium — The risk is medium because while a material agreement is reported, the specific terms and financial implications are not disclosed in this filing, creating uncertainty.
Analyst Insight
A smart investor would monitor Orgenesis Inc. (ORGS) for subsequent filings or press releases that detail the specifics of this 'Material Definitive Agreement' to understand its financial implications and strategic importance before making investment decisions.
Key Players & Entities
- Orgenesis Inc. (company) — the registrant filing the 8-K
- The Nasdaq Capital Market (company) — the exchange where Orgenesis's common stock is registered
- January 29, 2024 (date) — date of the earliest event reported
- January 31, 2024 (date) — date the 8-K was filed
FAQ
What is the specific nature of the 'Material Definitive Agreement' Orgenesis Inc. entered into?
The filing states that Orgenesis Inc. entered into a 'Material Definitive Agreement' on January 29, 2024, but it does not provide specific details about the nature or terms of this agreement. Further information would typically be disclosed in subsequent filings or press releases.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 29, 2024, which is the date Orgenesis Inc. entered into the Material Definitive Agreement.
What is the trading symbol for Orgenesis Inc. common stock?
The trading symbol for Orgenesis Inc. common stock is ORGS, and it is registered on The Nasdaq Capital Market.
What is the business address of Orgenesis Inc.?
The business address of Orgenesis Inc. is 20271 Goldenrod Lane, Germantown, MD 20876.
Why did Orgenesis Inc. file this 8-K?
Orgenesis Inc. filed this 8-K under Item 1.01, 'Entry into a Material Definitive Agreement,' to disclose a significant new agreement that the company entered into, as required by SEC regulations for events of material importance to shareholders.
Filing Stats: 1,382 words · 6 min read · ~5 pages · Grade level 16.1 · Accepted 2024-01-31 09:20:12
Key Financial Figures
- $40 m — od Payments (as defined in the UPA) for $40 million, consisting of cash and/or the Co
- $40 million — he Closing at a price that is more than $40 million excluding consideration for Excluded As
- $300,000 — th the Acquisition, subject to a cap of $300,000. In connection with the Acquisition,
- $2,600,000 — collective original principal amount of $2,600,000, were amended to, among other things, (
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex10-1.htm (EX-10.1) — 197KB
- 0001493152-24-004425.txt ( ) — 445KB
- orgs-20240129.xsd (EX-101.SCH) — 3KB
- orgs-20240129_lab.xml (EX-101.LAB) — 33KB
- orgs-20240129_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: January 31, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary